Internal Medicine, Infectious Disease · Evansville, IN
NPI
1205065737
Since 2009
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
520 Mary St Ste 230
Evansville, IN, 47710
Phone (812) 450-8600
Groups this clinician bills Medicare through
Medicare paid, 2024
$195K
2,673 services
Medicare patients, 2024
607
Average age 73
Drug cost, 2024
$394K
617 prescriptions
Company payments, 2025
$35.75
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Iass El Lakkis was code 99232 (hospital e&m - subsequent), 1,102 times for 420 patients. In total Iass El Lakkis billed 2,673 services in 17 codes, and Medicare paid $195K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-08-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 1,102 | 420 | $57.41 | $63K |
| 99233 Hospital E&M - Subsequent | Facility | 635 | 290 | $86.76 | $55K |
| 99231 Hospital E&M - Subsequent | Facility | 259 | 156 | $36.04 | $9,334 |
| 99222 Hospital E&M - Initial | Facility | 240 | 216 | $91.84 | $22K |
| 99223 Hospital E&M - Initial | Facility | 228 | 208 | $127.20 | $29K |
| 99214 Office E&M - Established | Office | 104 | 61 | $86.75 | $9,022 |
| 99221 Hospital E&M - Initial | Facility | 31 | 30 | $58.19 | $1,804 |
| 99204 Office E&M - New | Office | 28 | 28 | $109.64 | $3,070 |
| 99451 E&M - Miscellaneous | Office | 14 | 14 | $22.12 | $310 |
By year: 2022 $163K for 2,592 services; 2023 $159K for 2,246 services; 2024 $195K for 2,673 services.
Medicare prescription drug claims, 2024
In 2024, the drug Iass El Lakkis prescribed most often to Medicare patients was Vancomycin Hcl, with 58 prescriptions and refills. In total Iass El Lakkis wrote 617 Medicare prescriptions that cost $394K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Vancomycin Hcl Generic | 58 | 62 | 16 | $18K |
| Azithromycin Generic | 56 | 88 | 11 | $898 |
| Doxycycline Monohydrate Generic | 50 | 79 | 20 | $2,492 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 48 | 54 | 19 | $1,062 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 42 | 42 | Under 11 | $173K |
| Ethambutol Hcl Generic | 33 | 51 | Under 11 | $1,847 |
| Rifampin Generic | 32 | 61 | Under 11 | $1,593 |
| Daptomycin Generic | 28 | 28 | Under 11 | $33K |
| Ceftriaxone Ceftriaxone Sodium | 26 | 26 | Under 11 | $5,016 |
| Ampicillin-Sulbactam Ampicillin Sod/Sulbactam Sod | 25 | 25 | Under 11 | $4,026 |
| Amikacin Sulfate Generic | 18 | 20 | Under 11 | $5,079 |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 17 | 17 | Under 11 | $71K |
| Piperacillin-Tazobactam Piperacillin Sodium/Tazobactam | 14 | 14 | Under 11 | $5,083 |
| Cefepime Hcl Generic | 14 | 14 | Under 11 | $5,625 |
| Voriconazole Generic | 13 | 13 | Under 11 | $4,257 |
Brand drugs: 97 claims; generic drugs: 520 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Iass El Lakkis $35.75 ($35.75 in general payments such as food, travel and fees) from 1 company. The largest payer was Insmed, Inc. with $35.75.
| Company | Payments | Amount |
|---|---|---|
| Insmed, Inc. INSM | 2 | $35.75 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.